Skip to content
healthcare.dev

Oseltamivir Phosphate

NDC 0093-8180, Oseltamivir Phosphate, powder, for suspension, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-8180
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211125
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-8180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
0093-8180-64000938180641 BOTTLE in 1 CARTON (0093-8180-64) / 60 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ea5bf8f-c3fa-4d44-bc3d-b1912374ee4b
  • NADAC price for package 00093818064

    GET /v1/drugs/nadac/00093818064

Use it

Look up 0093-8180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-8180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-8180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.